Previous

NIH 1998 Almanac/The Organization/NIDA/      

National Institute on Drug Abuse: NIDA Legislative Chronology


1966--P.L. 89-793, the Narcotic Rehabilitation Act, provide for increased Federal effors in the rehabilitation and treatment of narcotic addicts (limited to opiate abusers).

1970--P.L. 91-513, the Comprehensive Drug Abuse Prevention and Control Act, replaced the PHS act's definition of "narcotic addict" with a definition of "drug dependent person" to authorize treatment for both narcotic addicts and other persons with drug abuse problems.

1972--P.L. 92-255, the Drug Abuse Office and Treatment Act, created a Special Action Office for Drug Abuse Prevention (SOADAP) and authorized a separate organizational entity--NIDA--within the Department to become operational in 1974. In cooperation with other Federal agencies, especially NIMH’s Division of Narcotic Addiction and Drug Abuse, SAODAP established a national network of multi-modality drug abuse treatment programs.

1974--P.L. 93-282, created ADAMHA which was charged with supervising the functions of NIMH, NIDA, and NIAAA.

Programs and responsibilities of DNADA and SAODAP were moved to NIDA.

1979--P.L. 96-181, the Drug Abuse Prevention, Rehabilitation, and Treatment Act, mandated that at least 7 percent in FY 1980 and 10 percent in FY 1881 of NIDA’s Community Programs budget be spent on prevention.

1981--P.L. 97-35, the Omnibus Budget Reconciliation Act, combined NIDA’s community programs project grants and contracts and formula grants within an ADM block grant giving more control of treatment and prevention services to the states.

1986--P.L. 99-570, the Anti-Drug Abuse Act of 1986, increased the block grant, created a substance abuse treatment enhancement to the block grant, and provided increased funds for AIDS research. Executive Order 12564 called for the implementation of a drug-free workplace. As a result of this action, NIDA created the Office of Workplace Initiatives.

1987--P.L. 100-71, Supplemental Appropriations Act of 1987, required DHHS (NIDA) to publish guidelines in the Federal Register for Federal drug testing.

1988--P.L. 100-690, the Anti-Drug Abuse Act of 1988, established the Office of National Drug Control Policy (ONDCP) and authorized funds for Federal, state and local law enforcement school-based drug prevention efforts and drug abuse treatment with special emphasis on injection drug abusers at high risk for AIDS.

1989 and 1990--P.L. 101-166 and P.L. 101-517, the Departments of Labor, HHS, and Eduation Appropriations Act for FY 1990 and 1991, contained identical prohibitions precluding the use of funds provided under these enactments to carry out any program of distributing sterile needles.

1992--P.L. 102-321, the ADAMHA Reorganization Act, transferred NIDA to NIH, earmarked 15 percent of the institute's research appropriation for health services research, established a Medication Development Program within NIDA, provided authority to designate Drug Abuse Research Centers for the purpose of interdisciplinary research relating to drug abuse and other biomedical, behavioral, and social issues related to drug abuse, and created an Office on AIDS at NIDA P.L. 102-394, the Departments of Labor, HHS, and Education FY 1993 Appropriations Act, provided that up to $2 million of NIDA research funds be available to carry out section 706 of P.L. 102-321, which required the DHHS Secretary, acting through NIDA, to request an NAS study U.S. programs that provide both sterile hypodermic needles and bleach.

1993--P.L. 103-112, the Labor/HHS and Education FY 1994 Appropriations Act, prohibited the use of funds under the act for 1) any further implementation of section 706 of P.L. 102-321 (see above).

1994 and 1996--P.L. 103-333, the Departments of Labor, HHS and Education Appropriations Act for FY 1995; P.L. 104-134, the Omnibus Consolidated Rescissions and Appropriations Act for FY 1996; P.L. 104-208, the Omnibus Consolidated Appro-priations Act for FY 1997--each prohibited use of any funds provided in the enactments to carry out any program of distributing sterile needles.

1997--The institute sponsored "Heroin Use and Addiction: A National Conference on Prevention, Treatment and Research," in Washington, D.C. NIDA released Preventing Drug Use Among Children and Adolescents: A Research-Based Guide, the first research-based guide to preventing young people from using drugs.

1998--NIDA established the Center for AIDS and Other Medical Consequences of Drug Abuse to coordinate a multidisciplinary research program on drug-related health problems.

1999--NIDA launched the National Drug Abuse Clinical Trials Network to rapidly and efficiently test the effectiveness of behavioral and pharmacological treatments in real-life settings. The institute released Principles of Drug Addiction Treatment: A Research-Based Guide, which describes the most successful concepts for treating people with drug abuse and addiction problems.


Previous



National Institutes of Health